Nanoparticle Drug Delivery Market To Treble by 2020
Nanoparticle drug deliver market will surpass USD 40 Billion by 2020
“...
albumin nanoparticles are gaining prominence rapidly and would soon become well-
established in the market across the glob...
of 2

Nanoparticle drug delivery market to treble by 2020

“Nanoparticle Drug Delivery Market & Clinical Pipeline Insight” Report Highlights:  Nanoparticle Drug Delivery Market Overview  Nanoparticle Drug Delivery Mechanism  Clinical Pipeline by Phase & Target Indications  Drug Profiles in Report: 190  Majority of Nanoparticle Drug in Preclinical Phase: 70  Marketed Nanoparticle Drugs: 12  Suspended & Discontinued Drug Profiles
Published on: Mar 3, 2016
Published in: Health & Medicine      
Source: www.slideshare.net


Transcripts - Nanoparticle drug delivery market to treble by 2020

  • 1. Nanoparticle Drug Delivery Market To Treble by 2020 Nanoparticle drug deliver market will surpass USD 40 Billion by 2020 “Nanoparticle Drug Delivery Market & Clinical Pipeline Insight” Report Highlights:  Nanoparticle Drug Delivery Market Overview  Nanoparticle Drug Delivery Mechanism  Clinical Pipeline by Phase & Target Indications  Drug Profiles in Report: 190  Majority of Nanoparticle Drug in Preclinical Phase: 70  Marketed Nanoparticle Drugs: 12  Suspended & Discontinued Drug Profiles Technologies based on Nanoparticles are likely to bring about a revolution in the methods in which drug delivery is achieved. These nanoparticles have been recognized as those having the potential to improve the efficacy of drugs, reduce the expected side effects, and enable appropriate and accurate target delivery. Thus, the drug delivery segment of the pharmaceutical industry is likely to be impacted the most due to the increasing use of nano technology. There is a rapid shift in the technology from polymer therapeutics to highly innovative approaches. The use of nanoparticles in the drug delivery systems is expected to change the horizon of medical treatment by positively impacting the economics and allowing for improved targeting of drugs into the appropriate part of the body without side effects or issues of toxicity. This is possible mainly because of the lower doses and increased focus on the effect where needed. The pharmaceutical companies, in recent years have identified the potential of nanoparticles in improving the entire process of drug delivery and thus leading to a better level of human health and quality of life for the patients. The combination of nanotechnology along with medicine has resulted in potential concepts and ideas for the pharma industry which is set to introduce momentous innovations in the fight against different diseases. The two concepts of therapeutic nanocarriers – liposomes and
  • 2. albumin nanoparticles are gaining prominence rapidly and would soon become well- established in the market across the globe. The need of the hour currently is to obtain a deeper understanding of the biodistribution of nanoparticles, which is influenced mainly by their ability to negotiate biological barriers. For Report Sample Visit: Nanoparticle Drug Delivery Market & Clinical Pipeline Insight Or Contact: avinash@kuickresearch.com

Related Documents